Evidence map›Paper›PMID 40627264›Full record

ReviewInfectious diseases and therapy2025

Long-Term Impacts of Invasive Meningococcal Disease on Survivors and Their Caregivers in the United States and Canada.

Todd Wolynn, John B Grimes, Sayali Nerurkar, Rachel Dawson, Katherine Galarza, Helay Hassas, Angie Upegui, David P Greenberg, Corwin A Robertson, Heather Entenmann and 3 more

Abstract readReview
In one paragraph

Review in Infectious diseases and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Todd WolynnPublic Good Projects, Pittsburgh, PA, USA.
John B GrimesPatient author, Frisco, TX, USA.
Sayali NerurkarAmaris Consulting, Toronto, ON, Canada.
Rachel DawsonSanofi Vaccines US, Morristown, NJ, USA.
Katherine GalarzaSanofi Vaccines US, Morristown, NJ, USA.
Helay HassasSanofi Vaccines US, Morristown, NJ, USA.
Angie UpeguiSanofi Vaccines Global, Lyon, France.
David P GreenbergSanofi Vaccines US, Morristown, NJ, USA.
Corwin A RobertsonSanofi Vaccines Global, Lyon, France.
Heather EntenmannSanofi Vaccines US, Morristown, NJ, USA.
Evan Jones MannAmaris Consulting, Barcelona, Spain.
Liga BennettsAmaris Consulting, 360 Rue Saint-Jacques, Montréal, QC, Canada. liga.bennetts@amaris.com.
Maureen P NearySanofi Vaccines US, Morristown, NJ, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAdolescents and young adults are among those most often impacted by invasive meningococcal disease (IMD), and survivors are often left with serious and permanent physical, neurological, psychological, or systemic complications. We conducted this targeted literature review with the primary goal of identifying evidence and evidence gaps relating to long-term health-related quality-of-life (HRQoL) and economic impacts for survivors who contracted IMD during adolescence or early adulthood and their caregivers.

methodsWe searched electronic databases and gray literature for studies assessing long-term clinical, HRQoL, and economic outcomes for patients who survived IMD in the US or Canada. Expert input provided by a survivor and patient advocate, as well as a pediatrician, was used to explore impacts and evidence gaps.

resultsEleven studies met the prespecified inclusion criteria for this review. Seven studies from the US and four from Canada reported on long-term outcomes of interest, including ten studies reporting clinical sequelae experienced by IMD survivors, three reporting HRQoL/social impacts, five reporting healthcare resource utilization, and four reporting direct costs. Across seven studies, 10.6-41% of IMD survivors had ≥ 1 sequelae, with prominent examples including seizures, deafness or hearing loss, stroke, amputation, skin scarring, and renal dysfunction or failure. Qualitative interviews and questionnaires revealed that survivors face significant and persistent emotional distress and physical impairment that limit daily functioning and social activities. Healthcare resource use, including inpatient stays and specialist visits following IMD was high, leading to substantial healthcare costs, especially among survivors with sequelae. Expert input highlighted that much of the burden encountered by survivors is not included in the published literature, including the cumulative out-of-pocket and indirect costs of living with sequelae for decades and the extent of the physical, psychological, and social impacts.

conclusionWhile published evidence suggests that survivors with sequelae from IMD during adolescence or young adulthood have long-term and significant humanistic and economic impacts, considerable and important evidence gaps remain.

Indexed as

Literature reviewLong-term comorbiditiesLong-term complicationsLong-term disabilitiesLong-term health-related quality of life burdenLong-term sequelaeMeningococcal diseaseNeisseria meningitidisPatient perspectivePhysician perspective

Identifiers

PMID40627264
PMCPMC12339822

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.